Personalized prostate pathology reporting: Focus on communication and clinical utility

Area of Science:

• Urology
• Oncology
• Pathology

Background:

• Histopathology is crucial for prostate cancer management, with current practices emphasizing accuracy and standardization.
• Prostate cancer diagnosis and management differ significantly from other cancers, impacting histopathological reporting.
• Nontargeted prostate biopsies are prone to sampling errors, limiting accurate tumor assessment.

Purpose of the Study:

• To review current prostate cancer histopathology reporting practices.
• To propose a simpler, clinically useful alternative approach to reporting.
• To enhance communication of essential histopathological findings.

Main Methods:

• Review of current literature and practices in prostate cancer histopathology.
• Analysis of the clinical utility of different histopathological parameters.
• Discussion of the implications of sampling error and serum markers like prostate-specific antigen (PSA).

Main Results:

• Current reporting practices face challenges due to sampling errors in biopsies.
• Definitive tumor data is often unavailable until radical prostatectomy.
• The clinical utility of histopathology can be enhanced by focusing on clinically significant data.

Conclusions:

• A pragmatic approach to prostate biopsy reporting is recommended.
• Less emphasis on precise tumor extent and grade determination may improve clinical utility.
• Focusing resources on clinically significant data enhances effective communication in prostate cancer management.